|
|
|
|
|
THIN - Data quality |
|
|
|
|
|
Recently, there have been two letters published which imply
data quality issues with The Health Improvement Network (THIN)
database. Apart from the potential conflict of interest of
the authors, we feel that their claims are not substantiated
and we demonstrate this below (Validation comments.pdf).
Since public debate often degenerates into a long series of
exchanges, we have decided to make researchers aware of our
interpretation of the stated concerns via our website. |
|
|
|
|
|
|
|
i
Van Staa TP, Parkinson J. Re: Use of cyclo-oxygenase 2
inhibitors (COX-2) and prescription non-steroidal
anti-inflammatory drugs. Pharmacoepidemiol Drug Saf,
2007; 16:1253-4
(NSAIDS)
in UK and USA populations: implications for COX-2
cardiovascular profile
ii
Van Staa TP, Parkinson J. Response to: validation studies of
the health improvement network (THIN) database for
pharmacoepidemiology research by Lewis et al.
Pharmacoepidemiol Drug Saf, 2008; 17:103-4 |
|
| |
|
|
|
